Skip to main content

Peer Review reports

From: Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

Original Submission
13 May 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 May 2013 Author responded Author comments - Gunnar Folprecht
Resubmission - Version 3
25 May 2013 Submitted Manuscript version 3
24 Jun 2014 Author responded Author comments - Gunnar Folprecht
26 Sep 2013 Reviewed Reviewer Report - Hans-Joachim Schmoll
6 Apr 2014 Reviewed Reviewer Report - Tae Won Kim
Resubmission - Version 4
24 Jun 2014 Submitted Manuscript version 4
Publishing
16 Jul 2014 Editorially accepted
19 Jul 2014 Article published 10.1186/1471-2407-14-521

You can find further information about peer review here.

Back to article page
\